1,566 results on '"Metzger, D."'
Search Results
2. A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF)
3. Carotid plaque characteristics in the CREST-2 trial
4. Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial
5. OP0030 PREDNISONE THERAPEUTIC EFFECT IN MYOSITIS DEPENDS ON Β-ADRENERGIC PATHWAY ACTIVATION INDUCED BY MYOFIBRES
6. Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study
7. Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES
8. Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES
9. Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD)
10. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
11. Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
12. Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)
13. Le co-traitement par bêtabloquants supprime l’efficacité thérapeutique de la prednisone au cours des myopathies inflammatoires
14. A First-in-Human Evaluation of a Novel Mesh-Covered Stent for Treatment of Carotid Stenosis in Patients at High Risk for Endarterectomy: 30-Day Results of the SCAFFOLD Trial
15. Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents
16. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial
17. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study
18. IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells
19. LB-8 | First in Human Safety and Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (The ENGULF Trial)
20. OR9-3 | Endovascular Outcomes of Patients with Heart Failure Undergoing Non-Stent Infrainguinal Interventions from the XLPAD Registry
21. Prevalence of Child and Adult Sexual Abuse and Risk Taking Practices Among HIV Serodiscordant African-American Couples
22. Effect of Baseline TIMI Thrombus Grade on Safety and Performance Outcomes in High Thrombus Burden Acute Coronary Syndrome Patients Treated With Sustained Mechanical Aspiration Thrombectomy Before Percutaneous Coronary Intervention: A Subset Analysis of the CHEETAH Study
23. Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy
24. Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
25. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)
26. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
27. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
28. Relation Between Renal Function and Coronary Plaque Morphology (from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Virtual Histology-Intravascular Ultrasound Substudy)
29. Chiral Symmetry Restoration at Finite Temperature in the Linear Sigma--Model
30. Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders
31. OP0119 MUSCLE FIBRE PLAYS A CRUCIAL ROLE IN THE THERAPEUTIC RESPONSE OF MYOSITIS TO GLUCOCORTICOIDS THROUGH THE PARACRINE EFFECT OF EPINEPHRINE ON THE IMMUNE SYSTEM
32. OP0117 PROTEASOME INHIBITION AS A NEW TREATMENT FOR DERMATOMYOSITIS: RESULTS OF A DRUG REPURPOSING ANALYSIS BASED ON THE TRANSCRIPTOMIC SIGNATURE OF PATIENTS’ PERIFASCICULAR FIBERS VALIDATED IN PRE-CLINICAL MODELS
33. Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial
34. Ligand-Activated Site-Specific Recombination in Mice
35. Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial)
36. Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy
37. The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study
38. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study
39. Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy
40. Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
41. Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial
42. Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study
43. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes From the IN.PACT SFA Randomized Trial
44. CRT-100.31 Effect of Baseline TIMI Thrombus Grade on Safety and Performance Outcomes in High Thrombus Burden Acute Coronary Syndrome Patients Treated With Sustained Mechanical Aspiration Thrombectomy Before Percutaneous Coronary Intervention: A Subset Analysis of the CHEETAH Study
45. One-year safety and effectiveness of the Alto abdominal stent graft in the ELEVATE IDE trial
46. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: “Window” Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
47. Comparison of Plaque Characteristics in Narrowings With ST-Elevation Myocardial Infarction (STEMI), Non-STEMI/Unstable Angina Pectoris and Stable Coronary Artery Disease (from the ADAPT-DES IVUS Substudy)
48. A New Murine Model of Sustainable and Durable Chronic Critical Limb Ischemia Fairly Mimicking Human Pathology
49. Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma
50. On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.